A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is
Purpose: To evaluate the efficacy of intraoperative sub-conjunctival injection of bevacizumab as an adjunct regiem to trabeculectomy for the treatment of refractory glaucoma. Design: Prospective randomized clinical trial. Patients and Methods: Fifty-five consecutive eyes scheduled for trabeculectomy were randomly included. In the study group (n= 30), bevacizumab (0.05 ml, 1.25 mg) was injected in the sub-conjunctiva adjacent to the bleb using a 30-gauge needle and tuberculin syringe immediatelydoi:10.4172/2155-9570.1000131 fatcat:3gh4raiylffvbk42inkwif4yga